Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 15, Issue 6, Pages 789-796
Publisher
Informa UK Limited
Online
2014-03-21
DOI
10.4161/cbt.28552
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-Associated Macrophages as a Paradigm of Macrophage Plasticity, Diversity, and Polarization
- (2013) Alberto Mantovani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain
- (2013) Xiaohui Wang et al. FASEB JOURNAL
- Cytokine Patterns in Brain Tumour Progression
- (2013) Radu Albulescu et al. MEDIATORS OF INFLAMMATION
- Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis
- (2012) Mingyong Han et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Aurintricarboxylic acid inhibits the nuclear factor-κB-dependent expression of intercellular cell adhesion molecule-1 and endothelial cell selectin on activated human endothelial cells
- (2011) Ji-Eun Kim et al. BLOOD COAGULATION & FIBRINOLYSIS
- Breast cancer statistics, 2011
- (2011) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Neutrophil interactions with sialyl Lewis X on human nonsmall cell lung carcinoma cells regulate invasive behavior
- (2011) Catherine A. St. Hill et al. CANCER
- Interactions between endothelial selectins and cancer cells regulate metastasis
- (2011) Catherine A. et al. Frontiers in Bioscience-Landmark
- The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
- (2011) Robert R. Langley et al. INTERNATIONAL JOURNAL OF CANCER
- E-selectin as a target for drug delivery and molecular imaging
- (2011) Emile Jubeli et al. JOURNAL OF CONTROLLED RELEASE
- Interaction of tumor cells and lymphatic vessels in cancer progression
- (2011) A Alitalo et al. ONCOGENE
- Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation
- (2011) Sachie Hiratsuka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Toll-Like Receptors in Angiogenesis
- (2011) Karsten Grote et al. TheScientificWorldJOURNAL
- Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
- (2010) Beate M. Lichtenberger et al. CELL
- Metastatic tumor cell arrest in the liver–lumen occlusion and specific adhesion are not exclusive
- (2009) Peter Gassmann et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking
- (2009) S. R. Barthel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The selectin–selectin ligand axis in tumor progression
- (2008) Isaac P. Witz CANCER AND METASTASIS REVIEWS
- Mechanisms by which E-Selectin Regulates Diapedesis of Colon Cancer Cells under Flow Conditions
- (2008) P.-L. Tremblay et al. CANCER RESEARCH
- Allergic Pulmonary Inflammation Promotes the Recruitment of Circulating Tumor Cells to the Lung
- (2008) A. G. Taranova et al. CANCER RESEARCH
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20
- (2007) Li Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started